Imaging tumor lactate is feasible for identifying intermediate-risk prostate cancer patients with postsurgical biochemical recurrence par Sushentsev, N, Hamm, G, Richings, J, McLean, MA, Menih, IH, Ayyappan, V, Mills, IG, Warren, AY, Gnanapragasam, VJ, Barry, ST, Goodwin, RJA, Gallagher, FA, Barrett, T

Metabolic imaging across scales reveals distinct prostate cancer phenotypes par Sushentsev, N, Hamm, G, Flint, L, Birtles, D, Zakirov, A, Richings, J, Ling, S, Tan, JY, McLean, MA, Ayyappan, V, Horvat Menih, I, Brodie, C, Miller, JL, Mills, IG, Gnanapragasam, VJ, Warren, AY, Barry, ST, Goodwin, RJA, Barrett, T, Gallagher, FA

Hyperpolarised 13C-MRI identifies the emergence of a glycolytic cell population within intermediate-risk human prostate cancer par Sushentsev, N, McLean, MA, Warren, AY, Benjamin, AJV, Brodie, C, Frary, A, Gill, AB, Jones, J, Kaggie, JD, Lamb, BW, Locke, MJ, Miller, JL, Mills, IG, Priest, AN, Robb, FJL, Shah, N, Schulte, RS, Graves, MJ, Gnanapragasam, VJ, Brindle, KM, Barrett, T, Gallagher, FA